No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors
Authors:
- Petra J. WoestenbergPWPetra J. Woestenberg
- Audrey J. KingAKAudrey J. King
- Marianne A.B. van der SandeMSMarianne A.B. van der Sande
- Robine DonkenRDRobine Donken
- Suzan LeussinkSLSuzan Leussink
- Fiona R.M. van der KlisFKFiona R.M. van der Klis
- Christian J.P.A. HoebeCHChristian J.P.A. Hoebe
- Johannes A. BogaardsJBJohannes A. Bogaards
- Birgit H.B. van BenthemBBBirgit H.B. van Benthem
- D. AdemaDAD. Adema
- R. Buist-ArkemaRBR. Buist-Arkema
- A. BeerensABA. Beerens
Open Access
- 1 April 2017
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 74 (4) , 393-400
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in WomenNew England Journal of Medicine, 2015
- Declining Genital Warts in Young Women in England Associated With HPV 16/18 Vaccination: An Ecological StudyThe Journal of Infectious Diseases, 2013
- Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected ObservationThe Journal of Infectious Diseases, 2013
- Patterns of Human Papillomavirus DNA and Antibody Positivity in Young Males and Females, Suggesting a Site-Specific Natural Course of InfectionPLOS ONE, 2013
- Seroprevalence of seven high-risk HPV types in The NetherlandsVaccine, 2012
- Type-Specific Human Papillomavirus Infections Among Young Heterosexual Male and Female STI Clinic AttendeesSexually Transmitted Diseases, 2012
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide studyThe Lancet Oncology, 2010
- Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trialBMJ, 2010
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) VaccineThe Journal of Infectious Diseases, 2009